196,40 €
0,03 % vorgestern
L&S, 24. Oktober, 22:55 Uhr
ISIN
US00287Y1091
Symbol
ABBV
Berichte

AbbVie Aktie News

Neutral
PRNewsWire
9 Tage alt
Acquisition expands AbbVie's psychiatry pipeline with the addition of a next-generation psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD). NORTH CHICAGO, Ill.
Positiv
The Motley Fool
10 Tage alt
The idea of steady money flowing in, year after year, should appeal to nearly everyone. This isn't an unrealistic dream; investing in stocks that pay reliable dividends can make it a reality.
Positiv
The Motley Fool
11 Tage alt
Dividend growth is a reliable edge. Over long periods, companies that regularly raise their dividends have often outperformed the benchmark S&P 500 (^GSPC 0.72%), as sustained payout increases typically stem from stronger, growing earnings.
Neutral
PRNewsWire
13 Tage alt
-        Updated indication allows the use of RINVOQ® (upadacitinib) prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom use of these treatments is clinically inadvisable and who have received at least one approved systemic therapy NORTH CHICAGO, Ill. , Oct. 13, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) ...
Neutral
The Motley Fool
13 Tage alt
Dividend stocks never go out of style, but they might be even more worthy of consideration right now because some evidence suggests that troubles lie ahead. The government shutdown and remaining uncertainty regarding tariffs could rock the economy or equity markets (or both).
Neutral
PRNewsWire
13 Tage alt
New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic, colorectal, and solid tumors, highlight progress in AbbVie's growing ADC portfolio designed to target difficult-to-treat cancers. NORTH CHICAGO, Ill.
Negativ
The Motley Fool
17 Tage alt
Carolina Wealth Advisors, LLC disclosed in an Oct. 7, 2025, U.S. Securities and Exchange Commission filing that it sold 38,267 AbbVie shares for the quarter ended Sept. 30, 2025, an estimated $7.79 million trade based on quarterly average pricing.
Neutral
PRNewsWire
17 Tage alt
By the makers of BOTOX® Cosmetic (onabotulinumtoxinA), SkinMedica®'s new packaging features a refreshed logo, modernized look, and luxe copper color palette. The brand's new HA5® moisturizer is designed to support the skin barrier and microbiome for bouncy, dewy, and soft skin.
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen